MYCN and neoplasm: Furthermore, in post-hoc exploratory analyses, nine (82%) of 11 patients with distantly relapsed diffuse MBSHH tumours had MYCN amplification at diagnosis, compared with two [25%] of eight patients with nodular MBSHH relapses (p=0·024; appendix p 5).